Mutations

Omicron subvariants EG.5 and XBB.2.3 are making inroads in the U.S.

Mon, 2023-07-10 17:01 — mike kraft

New COVID-19 Variants Giving ‘Arcturus’ a Run for its Money Omicron subvariants EG.5 and XBB.2.3 are making inroads in the U.S. Cecelia Smith-Schoenwalder US News & World Report

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Omicron subvariants EG.5 and XBB.2.3 are making inroads in the U.S.
Log in or register to post comments

Global COVID markers show few hot spots as XBB.1.16 overtakes XBB.1.5

Thu, 2023-06-29 18:38 — mike kraft

Global COVID markers show few hot spots as XBB.1.16 overtakes XBB.1.5 CIDRAP

Some countries continue to report high COVID-19 burdens, reflected mainly in hospitalization and death data, the World Health Organization (WHO) said in its latest weekly update. ..

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Global COVID markers show few hot spots as XBB.1.16 overtakes XBB.1.5
Log in or register to post comments

Study estimates 6-times-higher odds of COVID in households amid Omicron

Fri, 2023-06-23 10:33 — mike kraft

Study estimates 6-times-higher odds of COVID in households amid Omicron The odds of SARS-CoV-2 infection were 6.2 times greater in household contacts during Omicron than with previous strains, with rates even higher in kids. CIDRAP

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Study estimates 6-times-higher odds of COVID in households amid Omicron
Log in or register to post comments

Opinion: Former Surgeon General Jerome Adams: Prioritize oral antivirals for Covid

Thu, 2023-06-22 11:09 — mike kraft

Former Surgeon General Jerome Adams: Prioritize new antivirals for Covid "This is an issue of health equity," writes former Surgeon General Jerome Adams. Torie Bosch STAT

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Opinion: Former Surgeon General Jerome Adams: Prioritize oral antivirals for Covid
Log in or register to post comments

COVID-19 vaccination gives added protection against omicron infections in 5 to 17-year-olds--study

Wed, 2023-06-21 17:28 — mike kraft

Study: COVID-19 vaccination gives added protection against omicron infections in 5 to 17-year-olds A study by KK Women's and Children's Hospital (KKH), National Center for Infectious Disease and Ministry of Health in Singapore found that COVID-19 vaccination remained effective against omicron BA.4/BA.5 ... Science X

...

Five- to 11-year-old children who are vaccinated with two COVID-19 vaccine doses have the highest immunity against omicron infections prior to the first infection.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about COVID-19 vaccination gives added protection against omicron infections in 5 to 17-year-olds--study
Log in or register to post comments

FDA advisors endorse using only updated Covid vaccines

Thu, 2023-06-15 17:31 — mike kraft

FDA advisers endorse updating COVID vaccines to target latest omicron strain The COVID-19 vaccines are on track for a big recipe change this fall. Today’s vaccines still contain the original coronavirus strain, the one that started the pandemic. But that strain was long ago supplanted by mutated versions as the virus rapidly evolves. Scientific advisers for the Food and Drug Administration on Thursday said the next round of shots should only include protection against the newest omicron variants that are now dominant worldwide.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about FDA advisors endorse using only updated Covid vaccines
Log in or register to post comments

Monoclonal antibody injection prevented COVID-19 during Delta, Omicron

Thu, 2023-06-15 11:35 — mike kraft

Monoclonal antibody injection shown to prevent COVID-19 during Delta, Omicron The relative risk reduction for participants who received adintrevimab as post-exposure prophylaxis was 75%. CIDRAP

A single injection of the monoclonal antibody (mAb), adintrevimab prevented COVID-19 in the phase 2/3 EVADE trial, finds a study yesterday in Open Forum Infectious Diseases.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Monoclonal antibody injection prevented COVID-19 during Delta, Omicron
Log in or register to post comments

COVID shots should target XBB variants in 2023-24 campaign, US FDA staff say

Mon, 2023-06-12 18:05 — mike kraft

COVID shots should target XBB variants in 2023-24 campaign, US FDA staff say COVID-19 vaccines being developed and manufactured for the 2023-2024 campaign should target one of the currently dominant XBB variants, the U.S. Food and Drug Administration's (FDA) staff reviewers said on Monday. Reuters Reuters

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about COVID shots should target XBB variants in 2023-24 campaign, US FDA staff say
Log in or register to post comments

Opinion: We've made huge advances against COVID. Why is it still killing so many people?

Tue, 2023-06-06 10:11 — mike kraft

Opinion: We've made huge advances against COVID. Why is it still killing so many people? Many immunocompromised and older Americans feel abandoned. That's a public health failure. Yahoo News

...

why are so many people still dying? And how do we reconcile those numbers with the vast improvements in our COVID tools?

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Opinion: We've made huge advances against COVID. Why is it still killing so many people?
Log in or register to post comments

Bivalent COVID vaccine efficacy at 6 months drops 24% against hospitalization, strong against death --CDC study

Tue, 2023-05-30 17:48 — mike kraft

Bivalent COVID vaccine efficacy at 6 months: 24% against hospitalization, strong against death CIDRAP

Estimated bivalent (two-strain) COVID-19 mRNA vaccine effectiveness (VE) against hospitalization dropped from 62% 1 week after receipt to 24% at 4 to 6 months in adults with healthy immune systems, but protection against severe outcomes was sustained, according to a US Centers for Disease Control and Prevention (CDC) study.

...

Country / Region Tags:

General Topic Tags: